UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

BMC cancer, 2012-01, Vol.12 (1), p.39-39, Article 39

2012

Volltextzugriff (PDF)

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

Cancer & metabolism, 2019-06, Vol.7 (1), p.6-6, Article 6

2019

Volltextzugriff (PDF)

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

Breast cancer research : BCR, 2018-10, Vol.20 (1), p.120-120, Article 120

2018

Volltextzugriff (PDF)

Chemosensitivity and p53; new tricks by an old dog

Breast cancer research : BCR, 2012-11, Vol.14 (6), p.325-325, Article 325

2012

Volltextzugriff (PDF)

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R47-R47, Article R47

2012

Volltextzugriff (PDF)

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

Genome medicine, 2023-12, Vol.15 (1), p.104-15, Article 104

2023

Volltextzugriff (PDF)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors

BMC cancer, 2013-10, Vol.13 (1), p.456-456, Article 456

2013

Volltextzugriff (PDF)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Molecular cancer, 2010-03, Vol.9 (1), p.68-68, Article 68

2010

Volltextzugriff (PDF)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Genome medicine, 2022-08, Vol.14 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

BMC cancer, 2017-02, Vol.17 (1), p.97, Article 97

2017

Volltextzugriff (PDF)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Molecular cancer, 2006-10, Vol.5 (1), p.47-47

2006

Volltextzugriff (PDF)

Vascular proliferation is a prognostic factor in breast cancer

Breast cancer research and treatment, 2012-06, Vol.133 (2), p.501-510

2012

Volltextzugriff (PDF)

Assessment of tumor suppressor promoter methylation in healthy individuals

Clinical epigenetics, 2020-08, Vol.12 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

BMC cancer, 2012-10, Vol.12 (1), p.454-454, Article 454

2012

Volltextzugriff (PDF)

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Genome Biology, 2014-09, Vol.15 (9), p.447-447, Article 447

2014

Volltextzugriff (PDF)

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Clinical pharmacokinetics, 2003-01, Vol.42 (7), p.619-631

Lonning, Per E

2003

Volltextzugriff (PDF)

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

Molecular cancer, 2010-07, Vol.9 (1), p.173-173, Article 173

2010

Volltextzugriff (PDF)

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Breast cancer research and treatment, 2001-05, Vol.67 (2), p.111-116

2001

Volltextzugriff (PDF)

Prevalence of the CHEK2 R95 germline mutation

Hereditary cancer in clinical practice, 2016-09, Vol.14 (1), p.19-19, Article 19

2016

Volltextzugriff (PDF)

Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer

Breast cancer research and treatment, 1998-01, Vol.49 (S1), p.S45-S52

LØNNING, P. E

1998

Volltextzugriff (PDF)

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique

Cancer Immunology, Immunotherapy, 2006-10, Vol.55 (10), p.1280-1284

2006

Volltextzugriff (PDF)

Aromatase inhibitors and inactivators for breast cancer therapy

Drugs & aging, 2002, Vol.19 (4), p.277-298

LØNNING, Per E

2002

Volltextzugriff (PDF)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

BMC medical genomics, 2015-11, Vol.8 (73), p.73-73, Article 73

2015

Volltextzugriff (PDF)

Are current development programs realising the full potential of new agents?

Breast cancer research : BCR, 2010-12, Vol.12 Suppl 4 (Suppl 4), p.S23-S23, Article S23

Lanning, Per Eystein

2010

Volltextzugriff (PDF)

Tailored targeted therapy for all: a realistic and worthwhile objective?

Breast cancer research : BCR, 2009-01, Vol.11 Suppl 3 (S3), p.S7-S7, Article S7

Lønning, Per Eystein

2009

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionSpringerLink_现刊

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

Chemosensitivity and p53; new tricks by an old dog

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Vascular proliferation is a prognostic factor in breast cancer

Assessment of tumor suppressor promoter methylation in healthy individuals

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Prevalence of the CHEK2 R95 germline mutation

Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique

Aromatase inhibitors and inactivators for breast cancer therapy

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

Are current development programs realising the full potential of new agents?

Tailored targeted therapy for all: a realistic and worthwhile objective?

Aktive Filter

Suchergebnisse filtern